WallStreetZenWallStreetZen

NASDAQ: GRFS
Grifols Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GRFS

Based on 1 analyst offering 12 month price targets for Grifols Sa

Min Forecast
$10.00+21.95%
Avg Forecast
$10.00+21.95%
Max Forecast
$10.00+21.95%

Should I buy or sell GRFS stock?

Based on 1 analyst offering ratings for Grifols Sa.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GRFS stock forecasts and price targets.

GRFS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-08

1 of 1

Forecast return on equity

Is GRFS forecast to generate an efficient return?

Company
17.13%
Industry
-49.38%
Market
180.18%
GRFS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GRFS forecast to generate an efficient return on assets?

Company
4.71%
Industry
27.78%
GRFS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GRFS earnings per share forecast

What is GRFS's earnings per share in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$0.96+298.92%
Avg 2 year Forecast
$1.20+399.79%
Avg 3 year Forecast
$1.37+471.29%
GRFS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

GRFS revenue forecast

What is GRFS's revenue in the next 3 years based on estimates from 18 analysts?

Avg 1 year Forecast
$7.9B+5.49%
Avg 2 year Forecast
$8.4B+12.34%
Avg 3 year Forecast
$8.9B+18.2%
GRFS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GRFS earnings growth forecast

How is GRFS forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
75.83%
Industry
30.85%
Market
36.26%
GRFS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GRFS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GRFS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GRFS revenue growth forecast

How is GRFS forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
3.57%
Industry
9.29%
Market
13.59%
GRFS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GRFS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GRFS vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
GRFS$8.20$10.00+21.95%Hold
OGN$6.48$9.67+49.18%Strong Sell
AMRN$15.97N/AN/A
SCLX$8.65N/AN/A
MIRA$1.22N/AN/A
View Top General Drug Manufacturer Stocks

Grifols Sa Stock Forecast FAQ

Is Grifols Sa Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GRFS) stock is to Hold GRFS stock.

Out of 1 analyst, 0 (0%) are recommending GRFS as a Strong Buy, 0 (0%) are recommending GRFS as a Buy, 1 (100%) are recommending GRFS as a Hold, 0 (0%) are recommending GRFS as a Sell, and 0 (0%) are recommending GRFS as a Strong Sell.

If you're new to stock investing, here's how to buy Grifols Sa stock.

What is GRFS's earnings growth forecast for 2026-2028?

(NASDAQ: GRFS) Grifols Sa's forecast annual earnings growth rate of 75.83% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 30.85%, and it is also forecast to beat the US market's average forecast earnings growth rate of 36.26%.

Grifols Sa's earnings in 2026 is $174,355,555.On average, 16 Wall Street analysts forecast GRFS's earnings for 2026 to be $658,265,069, with the lowest GRFS earnings forecast at $464,924,629, and the highest GRFS earnings forecast at $779,687,266. On average, 14 Wall Street analysts forecast GRFS's earnings for 2027 to be $824,722,112, with the lowest GRFS earnings forecast at $592,947,353, and the highest GRFS earnings forecast at $967,389,756.

In 2028, GRFS is forecast to generate $942,706,534 in earnings, with the lowest earnings forecast at $673,803,810 and the highest earnings forecast at $1,111,776,286.

What is GRFS's revenue growth forecast for 2026-2028?

(NASDAQ: GRFS) Grifols Sa's forecast annual revenue growth rate of 3.57% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 9.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.59%.

Grifols Sa's revenue in 2026 is $8,013,757,777.On average, 18 Wall Street analysts forecast GRFS's revenue for 2026 to be $5,448,872,645,900, with the lowest GRFS revenue forecast at $5,098,907,197,728, and the highest GRFS revenue forecast at $5,855,905,151,436. On average, 15 Wall Street analysts forecast GRFS's revenue for 2027 to be $5,802,963,423,520, with the lowest GRFS revenue forecast at $5,361,553,172,584, and the highest GRFS revenue forecast at $6,383,259,765,872.

In 2028, GRFS is forecast to generate $6,105,487,583,040 in revenue, with the lowest revenue forecast at $5,651,701,343,760 and the highest revenue forecast at $6,581,963,134,284.

What is GRFS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: GRFS) forecast ROA is 4.71%, which is lower than the forecast US Drug Manufacturers - General industry average of 27.78%.

What is GRFS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GRFS price target, the average GRFS price target is $10.00, with the highest GRFS stock price forecast at $10.00 and the lowest GRFS stock price forecast at $10.00.

The Wall Street analyst predicted that Grifols Sa's share price could reach $10.00 by Dec 8, 2026. The average Grifols Sa stock price prediction forecasts a potential upside of 21.95% from the current GRFS share price of $8.20.

What is GRFS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: GRFS) Grifols Sa's current Earnings Per Share (EPS) is $0.26. On average, analysts forecast that GRFS's EPS will be $0.96 for 2026, with the lowest EPS forecast at $0.68, and the highest EPS forecast at $1.13. On average, analysts forecast that GRFS's EPS will be $1.20 for 2027, with the lowest EPS forecast at $0.86, and the highest EPS forecast at $1.41. In 2028, GRFS's EPS is forecast to hit $1.37 (min: $0.98, max: $1.62).

What is GRFS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: GRFS) forecast ROE is 17.13%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.